UBQLN2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.574200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.063000E-01
Normal-vs-Stage2
7.809800E-01
Normal-vs-Stage3
1.822430E-01
Normal-vs-Stage4
5.633200E-01
Stage1-vs-Stage2
1.463950E-01
Stage1-vs-Stage3
5.119500E-02
Stage1-vs-Stage4
8.219400E-01
Stage2-vs-Stage3
1.319770E-01
Stage2-vs-Stage4
1.236780E-01
Stage3-vs-Stage4
1.423980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.501200E-01
Normal-vs-AfricanAmerican
9.723200E-01
Normal-vs-Asian
7.318000E-01
Caucasian-vs-AfricanAmerican
8.327400E-01
Caucasian-vs-Asian
6.718200E-01
AfricanAmerican-vs-Asian
6.905000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.822400E-01
Normal-vs-Female
9.510400E-01
Male-vs-Female
4.365800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.677000E-01
Normal-vs-Age(41-60Yrs)
6.783200E-01
Normal-vs-Age(61-80Yrs)
6.465800E-01
Normal-vs-Age(81-100Yrs)
6.234800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.384200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.313200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.289430E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.739100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.985700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.860000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.879800E-01
Normal-vs-Daily Drinker
4.605000E-01
Normal-vs-Weekly Drinker
6.948600E-01
Normal-vs-Occasional Drinker
7.283000E-01
Normal-vs-Social Drinker
7.344000E-01
Non Drinker-vs-Daily Drinker
9.387400E-01
Non Drinker-vs-Weekly Drinker
6.220000E-01
Non Drinker-vs-Occasional Drinker
4.368400E-02
Non Drinker-vs-Social Drinker
5.700400E-02
Daily Drinker-vs-Weekly Drinker
5.912400E-01
Daily Drinker-vs-Occasional Drinker
5.019700E-02
Daily Drinker-vs-Social Drinker
6.398000E-02
Weekly Drinker-vs-Occasional Drinker
2.175000E-01
Weekly Drinker-vs-Social Drinker
2.406000E-01
Occasional Drinker-vs-Social Drinker
9.838200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.654000E-01
Normal-vs-Grade 2
5.822400E-01
Normal-vs-Grade 3
5.353000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.878000E-01
Grade 1-vs-Grade 3
4.840600E-01
Grade 1-vs-Grade 4
2.654000E-01
Grade 2-vs-Grade 3
2.078000E-01
Grade 2-vs-Grade 4
5.822400E-01
Grade 3-vs-Grade 4
5.353000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.874000E-01
Normal-vs-NonDiabetic
8.377800E-01
Diabetic-vs-NonDiabetic
3.167800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.869200E-01
Normal-vs-NoPancreatitis
7.860200E-01
Pancreatitis-vs-NoPancreatitis
7.730800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.746800E-01
Normal-vs-N1
7.656800E-01
N0-vs-N1
4.064400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.706400E-01
Normal-vs-TP53-NonMutant
9.400400E-01
TP53-Mutant-vs-TP53-NonMutant
8.105200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
